Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Investig Med High Impact Case Rep ; 7: 2324709619832324, 2019.
Article in English | MEDLINE | ID: mdl-30939936

ABSTRACT

Heparin-induced thrombocytopenia (HIT) type II is caused by antibody production that bind complexes between heparin and platelet factor 4 leading to platelet consumption and thrombosis. In a small subset of cases referred to as autoimmune HIT, the antibodies activate platelets even in the absence of heparin. Refractory HIT is a type of autoimmune HIT in which thrombocytopenia persists for weeks after heparin discontinuation and carries increased risk for thrombosis and more severe thrombocytopenia. We present a case of refractory HIT with cerebral venous sinus thrombosis (CVST) that was successfully treated with a change in anticoagulant alongside steroids and a second trial of intravenous immunoglobulin (IVIg).


Subject(s)
Anticoagulants/administration & dosage , Immunoglobulins, Intravenous/administration & dosage , Purpura, Thrombocytopenic, Idiopathic/drug therapy , Sinus Thrombosis, Intracranial/drug therapy , Steroids/administration & dosage , Anticoagulants/adverse effects , Anticoagulants/immunology , Autoantibodies/blood , Blood Platelets/drug effects , Blood Platelets/immunology , Female , Heparin/adverse effects , Heparin/immunology , Humans , Middle Aged , Purpura, Thrombocytopenic, Idiopathic/blood , Purpura, Thrombocytopenic, Idiopathic/chemically induced , Purpura, Thrombocytopenic, Idiopathic/immunology , Recurrence , Sinus Thrombosis, Intracranial/chemically induced
SELECTION OF CITATIONS
SEARCH DETAIL
...